Evidence map›Paper›PMID 24442768›Full record

ArticleProtein science : a publication of the Protein Society2014

The dynamics of interleukin-8 and its interaction with human CXC receptor I peptide.

Agnieszka A Kendrick, Michael J Holliday, Nancy G Isern, Fengli Zhang, Carlo Camilloni, Chi Huynh, Michele Vendruscolo, Geoffrey Armstrong, Elan Z Eisenmesser

Open access · bronzeAbstract read
In one paragraph

Article in Protein science : a publication of the Protein Society, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 34 citations in OpenAlex.

  1. SpyCEP dismantles neutrophil immunity via disorder-driven chemokine remodeling and GAG targeting.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Modulating Enzyme FunctionFrontiers in molecular biosciences · 2021
    Article
  10. Article
  11. Interleukin-37 monomer is the active form for reducing innate immunity.Proceedings of the National Academy of Sciences of the United States of America · 2019
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

Agnieszka A KendrickDepartment of Biochemistry and Molecular Genetics, School of Medicine, University of Colorado Denver, Aurora, Colorado, 80224.
Michael J Holliday
Nancy G Isern
Fengli Zhang
Carlo Camilloni
Chi Huynh
Michele Vendruscolo
Geoffrey Armstrong
Elan Z Eisenmesser
University of Colorado Denver · USUniversity of Cambridge · GBEnvironmental Molecular Sciences Laboratory · USNational High Magnetic Field Laboratory · USUniversity of Colorado Boulder · US

Funding

University of Colorado Cancer Center Support Grant - Lung Cancer Patient-Derived Xenografts with Autologous Human Immune SystemsP30CA046934 · NCI · UNIVERSITY OF COLORADO DENVER · PI James V Degregori · 1988 to 2026
$117.0M
Purchase of 900 MHz NMR SpectrometerP41GM068928 · NIGMS · UNIVERSITY OF COLORADO AT BOULDER · PI WUTTKE, DEBORAH S. · 2003 to 2009
$6.4M
Predoctoral Training Program in Molecular BiologyT32GM008730 · NIGMS · UNIVERSITY OF COLORADO DENVER · PI PREKERIS, RYTIS, SCLAFANI, ROBERT A · 1999 to 2019
$3.3M
EMMPRIN: from biology to molecular mechanismR01GM096019 · NIGMS · UNIVERSITY OF COLORADO DENVER · PI EISENMESSER, ELAN Z · 2011 to 2015
$1.4M
Combining chemical shift-based and experimental approaches to study enzyme dynamiR01GM107262 · NIGMS · UNIVERSITY OF COLORADO DENVER · PI EISENMESSER, ELAN Z · 2014 to 2017
$1.2M
The activity and molecular interactions of extracellular EMMPRINF31CA180392 · NCI · UNIVERSITY OF COLORADO DENVER · PI KENDRICK, AGNIESZKA ANASTAZJA · 2013 to 2015
$82k
NCI NIH HHS F31 CA180392NCI NIH HHS P30 CA046934NIGMS NIH HHS GM68928NIGMS NIH HHS R01 GM096019NIGMS NIH HHS R01 GM107262NIGMS NIH HHS T32 GM008730
6 · The paper itself

Abstract

Interleukin-8 (CXCL8, IL-8) is a proinflammatory chemokine important for the regulation of inflammatory and immune responses via its interaction with G-protein coupled receptors, including CXC receptor 1 (CXCR1). CXCL8 exists as both a monomer and as a dimer at physiological concentrations, yet the molecular basis of CXCL8 interaction with its receptor as well as the importance of CXCL8 dimer formation remain poorly characterized. Although several biological studies have indicated that both the CXCL8 monomer and dimer are active, biophysical studies have reported conflicting results regarding the binding of CXCL8 to CXCR1. To clarify this problem, we expressed and purified a peptide (hCXCR1pep) corresponding to the N-terminal region of human CXCR1 (hCXCR1) and utilized nuclear magnetic resonance (NMR) spectroscopy to interrogate the binding of wild-type CXCL8 and a previously reported mutant (CXCL8M) that stabilizes the monomeric form. Our data reveal that the CXCL8 monomer engages hCXCR1pep with a slightly higher affinity than the CXCL8 dimer, but that the CXCL8 dimer does not dissociate upon binding hCXCR1pep. These investigations also showed that CXCL8 is dynamic on multiple timescales, which may help explain the versatility in this interleukin for engaging its target receptors.

Indexed as

ThermodynamicsHumansInterleukin-8Magnetic Resonance SpectroscopyModels, MolecularPeptidesReceptors, Interleukin-8AInterleukin-8PeptidesReceptors, Interleukin-8Adimerdynamicshuman CXC receptor 1interleukin-8NMR

Identifiers

PMID24442768
PMCPMC3970897
OpenAlexW2099721600

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.